ABSTRACT
This study explored the role of acceptance in accounting for the heterogeneity in psychological functioning in adolescents suffering from cystic fibrosis. Thirty-four adolescents completed a battery of questionnaires assessing acceptance, anxiety, depression, and disability. Regression analyses revealed that acceptance had a significant and unique contribution in explaining adolescents' anxiety, depression, and disability beyond the effects of demographic variables and parameters of disease severity. Forced expiratory volume, a parameter of disease severity, had a unique contribution in explaining disability, but not in explaining anxiety and depression. Our results support the idea that accepting the limitations imposed by a chronic disease and readjusting life goals has a positive effect upon psychological functioning in adolescents with cystic fibrosis. Acceptance-based therapies might prove useful in promoting well-being in adolescents with cystic fibrosis.
Subject(s)
Adaptation, Psychological , Cystic Fibrosis/psychology , Adolescent , Anxiety/diagnosis , Child , Chronic Disease , Depression/diagnosis , Disability Evaluation , Female , Humans , Male , Regression Analysis , Severity of Illness Index , Surveys and Questionnaires , Young AdultABSTRACT
We report the cases of 3 patients in whom ajmaline-induced acute hepatitis was followed by anicteric cholestasis persisting for more than 1 year after cessation of administration of the drug. Ajmaline was given for 8-16 days before the onset of acute hepatitis. Jaundice was preceded by fever, chills and abdominal pain, and was associated with hypereosinophilia. The initial lesions included centrilobular cholestasis and portal inflammatory infiltration. Jaundice lasted for 3 weeks to 11 months. In these 3 patients liver tests were still abnormal 17-26 months after ajmaline withdrawal; histological examination, performed 9-26 months after the onset of jaundice, showed a decreased number of interlobular bile ducts, ductular proliferation, and mild portal fibrosis; circulating immune complexes were demonstrated. These observations demonstrate that prolonged cholestasis can follow ajmaline-induced acute hepatitis. Persistence of cholestasis long after the withdrawal of ajmaline suggests some form of autoimmunity.
